Scientech Research LLC purchased a new stake in Plexus Corp. (NASDAQ:PLXS – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 3,364 shares of the technology company’s stock, valued at approximately $347,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Plexus by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 3,515,866 shares of the technology company’s stock worth $333,374,000 after purchasing an additional 74,988 shares in the last quarter. Fiduciary Management Inc. WI boosted its holdings in Plexus by 3.8% in the fourth quarter. Fiduciary Management Inc. WI now owns 1,226,917 shares of the technology company’s stock worth $132,667,000 after acquiring an additional 44,398 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its stake in Plexus by 8.8% in the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,079,340 shares of the technology company’s stock valued at $111,366,000 after acquiring an additional 87,574 shares during the period. Earnest Partners LLC increased its holdings in shares of Plexus by 3.0% during the second quarter. Earnest Partners LLC now owns 788,196 shares of the technology company’s stock valued at $81,326,000 after acquiring an additional 23,074 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Plexus by 7.4% during the second quarter. Bank of New York Mellon Corp now owns 453,308 shares of the technology company’s stock worth $46,772,000 after purchasing an additional 31,099 shares during the period. 94.45% of the stock is owned by institutional investors and hedge funds.
Plexus Trading Up 0.2 %
NASDAQ PLXS opened at $136.71 on Tuesday. The company has a current ratio of 1.47, a quick ratio of 0.64 and a debt-to-equity ratio of 0.07. The business has a fifty day simple moving average of $125.01 and a 200 day simple moving average of $110.67. Plexus Corp. has a 12 month low of $87.21 and a 12 month high of $138.20. The firm has a market capitalization of $3.75 billion, a P/E ratio of 37.77 and a beta of 0.89.
Analyst Ratings Changes
Several analysts recently issued reports on PLXS shares. Benchmark lifted their price target on shares of Plexus from $120.00 to $145.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Needham & Company LLC boosted their target price on shares of Plexus from $114.00 to $144.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $124.00.
View Our Latest Stock Report on Plexus
Insider Transactions at Plexus
In related news, CEO Todd P. Kelsey sold 1,656 shares of the stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $115.00, for a total transaction of $190,440.00. Following the completion of the sale, the chief executive officer now directly owns 96,682 shares of the company’s stock, valued at $11,118,430. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Plexus news, CEO Todd P. Kelsey sold 1,656 shares of the business’s stock in a transaction on Tuesday, July 16th. The stock was sold at an average price of $115.00, for a total value of $190,440.00. Following the transaction, the chief executive officer now owns 96,682 shares of the company’s stock, valued at $11,118,430. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Steven J. Frisch sold 6,565 shares of the firm’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $128.11, for a total value of $841,042.15. Following the sale, the insider now directly owns 36,118 shares of the company’s stock, valued at $4,627,076.98. The disclosure for this sale can be found here. Insiders have sold 21,769 shares of company stock worth $2,731,834 in the last 90 days. Insiders own 2.39% of the company’s stock.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Articles
- Five stocks we like better than Plexus
- Conference Calls and Individual Investors
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- How to Find Undervalued Stocks
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- What is the Shanghai Stock Exchange Composite Index?
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.